Viamet to Present at American Chemical Society National Meeting

Viamet Pharmaceuticals, Inc. today announced that an overview of the Company’s metalloenzyme chemistry and biology technology will be presented at the American Chemical Society (ACS) National Meeting, to be held from August 16-20, 2015, in Boston, MA. The presentation will highlight the technology’s broad applicability to metalloenzyme targets across multiple therapeutic areas and its ability to deliver highly potent and selective compounds. William Hoekstra, Ph.D., Viamet’s Vice President of Medicinal Chemistry, will present, “Design and Optimization of Potent, Selective CYP51 Inhibitors.”